Invention Grant
- Patent Title: Substituted pyrazines for use in the treatment of inflammatory or allergic conditions
- Patent Title (中): 用于治疗炎症或过敏症状的取代吡嗪
-
Application No.: US12158481Application Date: 2006-12-20
-
Publication No.: US07803804B2Publication Date: 2010-09-28
- Inventor: Stephen Paul Collingwood , Nichola Smith
- Applicant: Stephen Paul Collingwood , Nichola Smith
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Fanelli Strain & Haag PLLC
- Agent Paul D. Strain, Esq.
- Priority: GB0526240.7 20051222
- International Application: PCT/EP2006/012314 WO 20061220
- International Announcement: WO2007/071396 WO 20070628
- Main IPC: A61K31/4965
- IPC: A61K31/4965
Abstract:
Disclosed herein are substituted pyrazine compounds and tautomers, stereoisomers, solvates, or pharmaceutically acceptable salts thereof for the treatment of conditions mediated by the blockade of an epithelial sodium channel, particularly an inflammatory or allergic condition, including compounds of formula I:
Public/Granted literature
- US20080312217A1 Organic Compounds Public/Granted day:2008-12-18
Information query
